These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22018662)

  • 21. Screening for acute human immunodeficiency virus infection in Baltimore public testing sites.
    Temkin E; Marsiglia VC; Hague C; Erbelding E
    Sex Transm Dis; 2011 May; 38(5):374-7. PubMed ID: 21183865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.
    Wesolowski LG; Delaney KP; Meyer WA; Blatt AJ; Bennett B; Chavez P; Granade TC; Owen M
    J Clin Virol; 2013 Sep; 58(1):240-4. PubMed ID: 23838670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.
    Masciotra S; Smith AJ; Youngpairoj AS; Sprinkle P; Miles I; Sionean C; Paz-Bailey G; Johnson JA; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e8-e12. PubMed ID: 24342483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further evaluation of alternative strategy for HIV testing in India.
    Chattopadhya D; Aggarwal RK; Kumari S
    J Commun Dis; 1996 Sep; 28(3):158-62. PubMed ID: 8973013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm.
    Wesolowski LG; Wroblewski K; Bennett SB; Parker MM; Hagan C; Ethridge SF; Rhodes J; Sullivan TJ; Ignacio-Hernando I; Werner BG; Owen SM
    J Clin Virol; 2015 Apr; 65():6-10. PubMed ID: 25766979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms.
    Kleinman SH; Stramer SL; Brodsky JP; Caglioti S; Busch MP
    Transfusion; 2006 May; 46(5):695-702. PubMed ID: 16686836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpretive criteria used to report western blot results for HIV-1-antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(40):692-5. PubMed ID: 1656186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current HIV-2 diagnostic strategy overestimates HIV-2 prevalence in China.
    Qiu M; Liu X; Jiang Y; Nkengasong JN; Xing W; Pei L; Parekh BS
    J Med Virol; 2009 May; 81(5):790-7. PubMed ID: 19319947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Would CLSI M53-A have helped in the diagnosis of HIV in Canada? Results of the performance of Canadian laboratories participating in a recent NLHRS proficiency testing panel containing HIV-1 antigen positive (antibody negative) and HIV-2 samples.
    Kadivar K; Malloch L; Adonsou-Hoyi Y; Ng D; Lavoie S; Pulido K; Kim J
    J Clin Virol; 2013 Sep; 58(1):303-5. PubMed ID: 23890809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa.
    Brattegaard K; Kouadio J; Adom ML; Doorly R; George JR; De Cock KM
    AIDS; 1993 Jun; 7(6):883-5. PubMed ID: 8395857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
    Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laboratory diagnosis of HIV infection in Papua New Guinea.
    Babona DV; Slama G; Puiahi E
    P N G Med J; 1996 Sep; 39(3):200-4. PubMed ID: 9795563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. OraSure HIV Clinical Trials Group.
    Gallo D; George JR; Fitchen JH; Goldstein AS; Hindahl MS
    JAMA; 1997 Jan; 277(3):254-8. PubMed ID: 9005276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of rapid HIV test kits on whole blood and development of rapid testing algorithm for voluntary testing and counseling centers in Ethiopia.
    Tegbaru B; Messele T; Wolday D; Meles PH; Tesema D; Birhanu H; Tesfaye G; Bond KB; Martin R; Rayfield MA; Wuhib T; Fekadu M
    Ethiop Med J; 2004 Oct; 42(4):267-76. PubMed ID: 16122118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Identification of variables associated with laboratory performance.
    Hancock JS; Taylor RN; Johnson CA; Gerber AR; Schalla WO
    Arch Pathol Lab Med; 1993 Nov; 117(11):1148-55. PubMed ID: 8239938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indeterminate human immunodeficiency virus western blot results in Iranian patients with discordant screening assay results.
    Ravanshad M; Mahboudi F; Sabahi F; Bayanolhagh S
    Saudi Med J; 2006 Aug; 27(8):1130-3. PubMed ID: 16883439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV single staging algorithm: integration and maximization of resources by reducing time between HIV diagnosis and treatment.
    Bennett B; Hardy B; Fordan S; Haddock-Morilla L; Rowlinson MC; Crowe S
    J Clin Virol; 2013 Dec; 58 Suppl 1():e34-7. PubMed ID: 23993447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot.
    Barbé F; Klein M; Badonnel Y
    Ann Biol Clin (Paris); 1994; 52(5):341-5. PubMed ID: 7856933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.